Health Promotion for the Sub-Optimal Health State of Asian Youths with Chronic Eczema: An Integrative Medicine Perspective

References

1. Hon K.L. Healthcare and health promotion for the sub-health state Hong Kong population. Hong Kong Med. J. 2021 27 73 10.12809/hkmj198370
   [Google Scholar]
2. Wang W. Yan Y. Guo Z. All around suboptimal health: A joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine. EPMA J. 2021 12 4 403 433 10.1007/s13167‑021‑00253‑2 34539937
   [Google Scholar]
3. Zhong Z. Chen S. Zhang X. Chen H. Li L. Suboptimal health among Chinese middle school students may be associated with psychological symptoms and sleep duration: A cross-sectional survey in China. BMC Public Health 2024 24 1 3137 10.1186/s12889‑024‑20658‑8 39533284
   [Google Scholar]
4. Fasseeh A.N. Elezbawy B. Korra N. Burden of atopic dermatitis in adults and adolescents: A systematic literature review. Dermatol. Ther. (Heidelb.) 2022 12 12 2653 2668 10.1007/s13555‑022‑00819‑6 36197589
   [Google Scholar]
5. Page M.J. McKenzie J.E. Bossuyt P.M. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021 372 n71 10.1136/bmj.n71 33782057
   [Google Scholar]
6. Saito H. Much atopy about the skin: Genome-wide molecular analysis of atopic eczema. Int. Arch. Allergy Immunol. 2005 137 4 319 325 10.1159/000086464 15970641
   [Google Scholar]
7. Hua T. Silverberg J.I. Atopic dermatitis in US adults. Ann. Allergy Asthma Immunol. 2018 121 5 622 624 10.1016/j.anai.2018.07.019 30036584
   [Google Scholar]
8. Chiesa Fuxench Z.C. Block J.K. Boguniewicz M. Atopic dermatitis in America Study: A cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the us adult population. J. Invest. Dermatol. 2019 139 3 583 590 10.1016/j.jid.2018.08.028 30389491
   [Google Scholar]
9. Deckers I.A.G. McLean S. Linssen S. Mommers M. van Schayck C.P. Sheikh A. Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: A systematic review of epidemiological studies. PLoS One 2012 7 7 e39803 10.1371/journal.pone.0039803 22808063
   [Google Scholar]
10. Vinding G. Zarchi K. Ibler K. Miller I. Ellervik C. Jemec G. Is adult atopic eczema more common than we think? - A population-based study in Danish adults. Acta Derm. Venereol. 2014 94 4 480 482 10.2340/00015555‑1761 24217962
    [Google Scholar]
11. Rönmark E.P. Ekerljung L. Lötvall J. Eczema among adults: Prevalence, risk factors and relation to airway diseases. Results from a large-scale population survey in Sweden. Br. J. Dermatol. 2012 166 6 1301 1308 10.1111/j.1365‑2133.2012.10904.x 22372948
    [Google Scholar]
12. Mortz C.G. Andersen K.E. Dellgren C. Barington T. Bindslev-Jensen C. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities. Allergy 2015 70 7 836 845 10.1111/all.12619 25832131
    [Google Scholar]
13. Odhiambo J.A. Williams H.C. Clayton T.O. Robertson C.F. Asher M.I. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J. Allergy Clin. Immunol. 2009 124 6 1251 1258.e23 10.1016/j.jaci.2009.10.009 20004783
    [Google Scholar]
14. Alghamdi A. Alanazi S. Prevalence of atopic dermatitis among pediatric and adult patients: A cross-sectional study at King Abdulaziz Medical City, Riyadh, Saudi Arabia. Discov. Med. 2025 2 1 10 10.1007/S44337‑025‑00223‑X
    [Google Scholar]
15. Silverberg J.I. Barbarot S. Gadkari A. Atopic dermatitis in the pediatric population. Ann. Allergy Asthma Immunol. 2021 126 4 417 428.e2 10.1016/j.anai.2020.12.020 33421555
    [Google Scholar]
16. McKenzie C. Silverberg J.I. The prevalence and persistence of atopic dermatitis in urban United States children. Ann. Allergy Asthma Immunol. 2019 123 2 173 178.e1 10.1016/j.anai.2019.05.014 31128232
    [Google Scholar]
17. Lloyd-Lavery A. Solman L. Grindlay D.J.C. Rogers N.K. Thomas K.S. Harman K.E. What’s new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: Epidemiology, aetiology and risk factors. Clin. Exp. Dermatol. 2019 44 4 370 375 10.1111/ced.13853 30706503
    [Google Scholar]
18. Fu T. Keiser E. Linos E. Eczema and sensitization to common allergens in the United States: a multiethnic, population-based study. Pediatr. Dermatol. 2014 31 1 21 26 10.1111/pde.12237 24283549
    [Google Scholar]
19. Silverberg J.I. Simpson E.L. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr. Allergy Immunol. 2013 24 5 476 486 10.1111/pai.12095 23773154
    [Google Scholar]
20. Gerner T. Haugaard J.H. Vestergaard C. Disease severity and trigger factors in Danish children with atopic dermatitis: a nationwide study. J. Eur. Acad. Dermatol. Venereol. 2021 35 4 948 957 10.1111/jdv.17007 33078461
    [Google Scholar]
21. Sandström M.H. Faergemann J. Prognosis and prognostic factors in adult patients with atopic dermatitis: A long-term follow-up questionnaire study. Br. J. Dermatol. 2004 150 1 103 110 10.1111/j.1365‑2133.2004.05711.x 14746623
    [Google Scholar]
22. Lee H.H. Patel K.R. Singam V. Rastogi S. Silverberg J.I. A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J. Am. Acad. Dermatol. 2019 80 6 1526 1532.e7 10.1016/j.jaad.2018.05.1241 29864464
    [Google Scholar]
23. Lam P.H. Hon K.L. Loo S. Li C.K. Ip P. Koh M.J. Mental health among parents and their children with eczema in Hong Kong. Hong Kong Med. J. 2024 30 362 370 10.12809/hkmj219738
    [Google Scholar]
24. Hon K.L. Leong K.F. Leung T.N.H. Leung A.K.C. Dismissing the fallacies of childhood eczema management: Case scenarios and an overview of best practices. Drugs Context 2018 7 1 12 10.7573/dic.212547 30532792
    [Google Scholar]
25. Hon K.L.E. Leung T.F. Kam W.Y.C. Lam M.C.A. Fok T.F. Ng P.C. Dietary restriction and supplementation in children with atopic eczema. Clin. Exp. Dermatol. 2006 31 2 187 191.(Suppl.) 10.1111/j.1365‑2230.2005.02002.x
    [Google Scholar]
26. Cohen M.H. Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation. Dermatol. Ther. 2003 16 2 77 84 10.1046/j.1529‑8019.2003.01614.x 12919107
    [Google Scholar]
27. Cohen M.H. Hrbek A. Davis R.B. Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: A descriptive study of 19 integrative health care centers in the United States. Arch. Intern. Med. 2005 165 3 289 295 10.1001/archinte.165.3.289 15710791
    [Google Scholar]
28. Hon K.L. Leung A.K.C. Leung T.N.H. Lee V.W.Y. Complementary, alternative and integrative medicine for childhood atopic dermatitis. Recent Pat. Inflamm. Allergy Drug Discov. 2017 11 2 114 124 10.2174/1872213X11666171128142333
    [Google Scholar]
29. Hon K.L. Chu S. Leung A.K.C. Wong A. Atopic dermatitis: Conventional and integrative medicine. Curr. Pediatr. Rev. 2022 18 2 84 96 10.2174/1573396317666210716152325 34279204
    [Google Scholar]
30. Wang Z. Wang Z.Z. Geliebter J. Tiwari R. Li X.M. Traditional Chinese medicine for food allergy and eczema. Ann. Allergy Asthma Immunol. 2021 126 6 639 654 10.1016/j.anai.2020.12.002 33310179
    [Google Scholar]
31. Itamura R. Effect of homeopathic treatment of 60 Japanese patients with chronic skin disease. Complement. Ther. Med. 2007 15 2 115 120 10.1016/j.ctim.2006.04.005 17544862
    [Google Scholar]
32. Itamura R. Hosoya R. Homeopathic treatment of Japanese patients with intractable atopic dermatitis. Homeopathy 2003 92 2 108 114 10.1016/S1475‑4916(03)00017‑1 12725253
    [Google Scholar]
33. Nakahara T. Takemoto S. Houzawa H. Nakayama M. Desire for alternative treatment options in patients with atopic dermatitis in Japan: Results of a web-based cross-sectional study (AD-JOIN Study). Dermatol. Ther. (Heidelb.) 2022 12 6 1383 1396 10.1007/s13555‑022‑00738‑6 35583611
    [Google Scholar]
34. Hon K.E. Ma K.C. Wong Y. Leung T.F. Fok T.F. A survey of traditional Chinese medicine use in children with atopic dermatitis attending a paediatric dermatology clinic. J. Dermatolog. Treat. 2005 16 3 154 157.(Suppl.) 10.1080/09546630510038938 16096181
    [Google Scholar]
35. Love in the Time of Eczema: 3 Influencers Get Real About Dating With a Chronic Skin Condition. 2025 Available from: www.webmd.com/skin-problems-and-treatments/eczema/features/3-influencers-get-real-about-dating-with-chronic-skin-condition.
36. NICOLA | Eczema and sensitive skin. Available from: https://www.instagram.com/nicolaljohnston/?hl=en
37. My Journey as a Skin Influencer: Battling Eczema By Showcasing The Skin I’m In. 2023 Available from: https://thoughtcatalog.com/harriet-williams/2023/10/my-journey-as-a-skin-influencer-battling-eczema-not-letting-it-hold-me-back/.
38. Hon K.L. Leung K.K.Y. Lin W.L. Luk D.C.K. A critically ill infant with multi-organ dysfunction due to eczema. Hong Kong Med. J. 2022 28 e1 e3 10.12809/hkmj208904
    [Google Scholar]
39. Hon K.L. Nip S.Y. Cheung K.L. A tragic case of atopic eczema: malnutrition and infections despite multivitamins and supplements. Iran. J. Allergy Asthma Immunol. 2012 11 3 267 270 22947914
    [Google Scholar]
40. Wollenberg A. Kinberger M. Arents B. European Guideline (EuroGuiDerm) on atopic eczema: Living update. J. Eur. Acad. Dermatol. Venereol. 2025 2025 1 30 10.1111/jdv.20639 40317496
    [Google Scholar]
41. Wollenberg A. Kinberger M. Arents B. European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations. J. Eur. Acad. Dermatol. Venereol. 2022 36 11 1904 1926 10.1111/jdv.18429 36056736
    [Google Scholar]
42. Wollenberg A. Kinberger M. Arents B. European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy. J. Eur. Acad. Dermatol. Venereol. 2022 36 9 1409 1431 10.1111/jdv.18345 35980214
    [Google Scholar]
43. Chu D.K. Schneider L. Asiniwasis R.N. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations. Ann. Allergy Asthma Immunol. 2024 132 3 274 312 10.1016/j.anai.2023.11.009 38108679
    [Google Scholar]
44. Leung T.N.H. Cheng J.W.C.H. Management of atopic dermatitis in children: 2020 review by the guidelines development panel of Hong Kong college of paediatricians. Hong Kong J. Paediatr. 2021 3 26
    [Google Scholar]
45. Matthews S.J. Housam N. Lawton S. Taverner P. Atopic eczema in under 12s: diagnosis and management—summary of updated NICE guidance. BMJ 2023 382 1538 10.1136/bmj.p1538 37487606
    [Google Scholar]
46. Hon K.L. An overview of drug discovery efforts for eczema: why is this itch so difficult to scratch? Expert Opin. Drug Discov. 2020 4 487 10.1080/17460441.2020.1722639
    [Google Scholar]